All of Us Expands Enrollment and Engagement Efforts with New Awardees
Doug Lindsay, ICTS Community Advisory Board Co-Chair, Appointed to PCORI’s Rare Disease Advisory Panel
Lindsay to serve as co-chair for the Patient-Centered Outcomes Research Institute’s (PCORI) Advisory Panel on Rare Diseases, one of five multi-stakeholder advisory panels.
Immune modulator drugs for COVID-19 focus of major NIH clinical trial
Phase 3 trial involves hospitalized patients with moderate to severe disease
MU Team Wins Honorable Mention in NCATS “Rare Diseases Are Not Rare” Challenge
Congratulations to ICTS investigator, Jonathan Bath, MD, assistant professor of surgery at the University of Missouri-Columbia School of Medicine and medical student Danielle Kinsey on their honorable mention in the NCATS Rare Diseases Are Not Rare 2020 Challenge .
Basis of developmental disabilities focus of $11.3 million in grants
Researchers at Washington University School of Medicine in St. Louis have received a pair of grants totaling $11.3 million to study genetic and environmental factors that contribute to developmental disabilities and to find new ways to improve the lives of children and adults affected by such disabilities.
Antibodies protect against wide range of influenza B virus strains
Pieces of four antibodies (turquoise) attach to a protein from influenza B virus (gray) in the colorized cryo-electron microscopy reconstruction. Researchers at Washington University School of Medicine in St. Louis and Icahn School of Medicine at Mount Sinai have identified two antibodies that protect mice against lethal infections of influenza B virus.